- Home
- HFBL vs CERO Comparison
HFBL vs CERO Comparison
Compare HFBL & CERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HFBL
- CERO
- Stock Information
- Founded
- HFBL 1924
- CERO 2017
- Country
- HFBL United States
- CERO United States
- Employees
- HFBL N/A
- CERO N/A
- Industry
- HFBL Savings Institutions
- CERO
- Sector
- HFBL Finance
- CERO
- Exchange
- HFBL Nasdaq
- CERO Nasdaq
- Market Cap
- HFBL 39.4M
- CERO 36.0M
- IPO Year
- HFBL N/A
- CERO N/A
- Fundamental
- Price
- HFBL $12.29
- CERO $0.24
- Analyst Decision
- HFBL
- CERO
- Analyst Count
- HFBL 0
- CERO 0
- Target Price
- HFBL N/A
- CERO N/A
- AVG Volume (30 Days)
- HFBL 2.1K
- CERO 178.7M
- Earning Date
- HFBL 10-29-2024
- CERO 11-19-2024
- Dividend Yield
- HFBL 4.24%
- CERO N/A
- EPS Growth
- HFBL N/A
- CERO N/A
- EPS
- HFBL 1.09
- CERO N/A
- Revenue
- HFBL $19,727,000.00
- CERO N/A
- Revenue This Year
- HFBL N/A
- CERO N/A
- Revenue Next Year
- HFBL N/A
- CERO N/A
- P/E Ratio
- HFBL $11.30
- CERO N/A
- Revenue Growth
- HFBL N/A
- CERO N/A
- 52 Week Low
- HFBL $10.60
- CERO $0.06
- 52 Week High
- HFBL $15.81
- CERO $12.80
- Technical
- Relative Strength Index (RSI)
- HFBL 46.34
- CERO 65.04
- Support Level
- HFBL $12.14
- CERO $0.22
- Resistance Level
- HFBL $12.40
- CERO $0.29
- Average True Range (ATR)
- HFBL 0.19
- CERO 0.05
- MACD
- HFBL -0.01
- CERO 0.01
- Stochastic Oscillator
- HFBL 31.58
- CERO 49.37
About HFBL Home Federal Bancorp Inc. of Louisiana
Home Federal Bancorp Inc of louisiana operates as a bank holding company. It is a federally chartered stock savings bank, which provides financial services to individuals, corporate entities, and other organizations. Its core activities consist of attracting deposits from the general public and using those funds to originate loans to the residential, commercial and multi-family segments. The company also invests securities held-to-maturity and securities available for sale.
About CERO CERo Therapeutics Holdings Inc. Common Stock
CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T-cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy.